Clinical trial

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

NCT06352619

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-11

PhaseNA

Study timeline

Study start (actual)2024-10-11Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ischemic Stroke, Acuteunresolved

Interventions

Conservative SBP ControlOTHER

Moderate SBP ControlOTHER

Intensive SBP ControlOTHER

Sponsors & collaborators

The George Institutelead sponsor

University of Calgarycollaborator

Changhai Hospitalcollaborator

Mapped research locations

CalgaryAlberta, Canada1 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06352619 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.